Expansion of Private Equity Involvement in Women’s Health Care

Citation:

Bruch, Joseph D., Alexander Borsa, Zirui Song, and Sarah S. Richardson. “Expansion of Private Equity Involvement in Women’s Health Care.” JAMA Internal Medicine 180, no. 11 (2020): 1542–1545. Copy at https://j.mp/3nUuHGr

Abstract:

We document formerly non–private equity women’s health care companies, including physician networks, practices, and fertility clinics, that gained a private equity affiliation between 2010 and 2019. This analysis shows a substantial increase in private equity affiliations in women’s health care since 2017. Private equity–affiliated OB/GYN offices are located in urban locations, with an average 2017 median household income 24% higher than the 2017 national average. How the incentives of private equity firms interact with the clinical mission of women’s health is a critical area of inquiry. Future debate about private equity in women’s health will likely be shaped by the associations between economic incentives and quality of care, elective or cosmetic procedures, and access to reproductive health services, especially among low-income, LGBTQIA, and other disadvantaged populations.

Commentary: Private Equity, Women’s Health, and the Corporate Transformation of American Medicine

Publisher's Version